Validation of a tool to assess medication treatment satisfaction in patients with Type2 diabetes: The Diabetes Medication System Rating Questionnaire (DMSRQ)

Diabetic Medicine

Volumn 29, Issue 8, 2012, Pages 1060-1066

  Peyrot, M ^a   Harshaw, Q ^b   Shillington, A C ^b   Xu, Y ^c   Rubin, R R ^d  

^a LOYOLA UNIVERSITY MARYLAND   (United States)

^b EPI Q Inc   (United States)

^c GENENTECH INC   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Medicine; Patient satisfaction; Questionnaire

Indexed keywords

EXENDIN 4; GLUCOSE; INSULIN; LIRAGLUTIDE; ORAL ANTIDIABETIC AGENT;

ADULT; AMERICAN INDIAN; ARTICLE; ASIAN; CAUCASIAN; DIABETES MEDICATION SYSTEM RATING QUESTIONNAIRE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MOOD; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PACIFIC ISLANDER; PATIENT COMPLIANCE; PATIENT PREFERENCE; PATIENT SATISFACTION; PSYCHOLOGICAL WELL BEING; QUESTIONNAIRE; RELIABILITY; VALIDITY;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84863999108     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03538.x     Document Type: Article

References (17)

1. Nathan DM, Buse JB, Davidson MB, Ferannini E, Holman RR, Sherwin R et al. Medical management of hyperglycemia in type2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 29: 193-203.
2. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15: 205-218.
3. Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type2 diabetes. Diabetes Care 2008; 31: 430-432.
4. Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type2 diabetes: a retrospective database analysis. Clin Ther 2008; 29: 1294-1305.
5. Charpentier G, Fleury F, Dubroca I, Vaur L, Clerson P. Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance. Diabetes Metab 2005; 31: 189-195.
6. Kelley K, Dempsey C. An evaluation of an insulin transfer programme delivered in a group setting. J Clin Nurs 2007; 16: 152-158.
7. Tahrani AA, Digwood S, Lee C, Moulilk P. Evaluation of glargine group-start sessions in patients with type2 diabetes as a strategy to deliver the service. Int J Clin Pract 2007; 61: 329-335.
8. Alvarez Guisasola A, Tofe Povedano S, Krishnaraja G, Lyu R, Mavros P, Yin D. Hyperglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obesity Metab 2008; 10: S25-S32.
9. Bradley C. The Diabetes Treatment Satisfaction Questionnaire: DTSQ. In: Bradley C, ed. Handbook of Psychology and Diabetes: a Guide to Psychological Measurement in Diabetes Research and Practice. Chur, Switzerland: Harwood Academic Publishers, 1994: 111-132.
10. Peyrot M, Rubin RR. Validation and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Questionnaire. Diabetes Care 2005; 28: 53-58.
11. Rubin RR, Peyrot M. Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the Inhaled Insulin Treatment Questionnaire (IITQ). Health Quality Life Outcomes 2010; 8: 32.
12. Rubin RR, Peyrot M. Psychometric properties of an instrument for assessing treatment satisfaction associated with pramlintide use. Diabetes Educ 2009; 35: 136-146.
13. Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM VersionII) among outpatient pharmacy consumers. Value Health 2005; 8: s9-s24.
14. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertension 2008; 10: 348-354.
15. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care 2003; 41: 582-592.
16. Cohen J. Statistical Power Analysis for the Behavioral Sciences. London: Academic Press, 1969.
17. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004; 27: 2495-2497.